Literature DB >> 15015761

Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice.

K Manda1, A L Bhatia.   

Abstract

The present study investigated the prophylactic influence of melatonin against cyclophosphamide-induced oxidative stress in mouse tissues. Lipid peroxidation, reduced glutathione (GSH), glutathione disulphide (GSSG), glutathione peroxidase (GSH-Px) and serum phosphatase levels were analyzed in brain, spleen liver, lungs, kidney and testes. Fifteen days oral administration with melatonin (0.1 mg/kg bw per day) before treatment checked the augmentation of the level of lipid peroxidation, blood GSSG and acid phosphatase caused by an acute treatment with a radiomimetic drug, cyclophosphamide (75 mg/kg bw). Cyclophosphamide-induced depletion in the level of GSH, GSH-Px and alkaline phosphatase was made up statistically significant by chronic melatonin administration given orally. The results indicate the antioxidative properties of melatonin resulting into its prophylactic property against the cyclophosphamide-induced biochemical alterations. The finding support the idea that melatonin is a potent free-radical scavenger and antioxidant.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15015761     DOI: 10.1023/b:cbto.0000013342.17370.16

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  26 in total

Review 1.  Hepatoprotective actions of melatonin: possible mediation by melatonin receptors.

Authors:  Alexander M Mathes
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  Protective effect of aminoguanidine against cyclophosphamide-induced oxidative stress and renal damage in rats.

Authors:  Premila Abraham; Suganthy Rabi
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

3.  Mitigation of oxidative stress in cyclophosphamide-challenged hepatic tissue by DL-alpha-lipoic acid.

Authors:  Elangovan Selvakumar; Chidambaram Prahalathan; Yenjerla Mythili; Palaninathan Varalakshmi
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

4.  Nano-Se attenuates cyclophosphamide-induced pulmonary injury through modulation of oxidative stress and DNA damage in Swiss albino mice.

Authors:  Arin Bhattacharjee; Abhishek Basu; Jaydip Biswas; Sudin Bhattacharya
Journal:  Mol Cell Biochem       Date:  2015-04-29       Impact factor: 3.396

5.  Rapamycin inhibits acrolein-induced apoptosis by alleviating ROS-driven mitochondrial dysfunction in male germ cells.

Authors:  X He; W Song; C Liu; S Chen; J Hua
Journal:  Cell Prolif       Date:  2014-01-31       Impact factor: 6.831

6.  The cyclophosphamide metabolite, acrolein, induces cytoskeletal changes and oxidative stress in Sertoli cells.

Authors:  Feng Liu; Xu-Liang Li; Tao Lin; Da-Wei He; Guang-Hui Wei; Jun-Hong Liu; Lu-Sheng Li
Journal:  Mol Biol Rep       Date:  2011-05-08       Impact factor: 2.316

Review 7.  Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits.

Authors:  Tonya S Orchard; Monica M Gaudier-Diaz; Kellie R Weinhold; A Courtney DeVries
Journal:  Breast Cancer Res Treat       Date:  2016-12-08       Impact factor: 4.872

8.  Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models.

Authors:  Yingjen Jeffrey Wu; Leslie L Muldoon; Dana Thomas Dickey; Seth J Lewin; Csanad G Varallyay; Edward A Neuwelt
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

9.  Osteolineage niche cells initiate hematopoietic stem cell mobilization.

Authors:  Shane R Mayack; Amy J Wagers
Journal:  Blood       Date:  2008-05-02       Impact factor: 22.113

10.  Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy.

Authors:  Lizzia Raffaghello; Changhan Lee; Fernando M Safdie; Min Wei; Federica Madia; Giovanna Bianchi; Valter D Longo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.